This handicap is likely to be strongly run and I think that could suit Saturn Five who has raced keenly on both starts since returning from a long break. He made an encouraging return to action at ...

Since Voyager 1 blasted off in 1977, it has skirted past the kaleidoscopic clouds of Jupiter and the icy rings of Saturn. The spacecraft is now 124 times farther from the Sun than we are ...

Voyager Therapeutics (VYGR ... You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current ...

LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $31 million in its first quarter. On a per-share basis, the Lexington ...

Werewolf Therapeutics, Inc.'s revenues are expected to be $1.5 million, up 102.7% from the year-ago quarter. Should You Invest in Voyager Therapeutics, Inc. (VYGR)? Before you invest in Voyager ...

Alongside a crescent moon, Mercury, Venus and Saturn will become visible to stargazers just before dawn on Friday morning. According to NASA, the planetary phenomenon will be clearest about 45 ...

Free funds flow (1) of $57.8 million ($0.29/share basic) contributed cash to the balance sheet and further bolstered Saturn's financial flexibility. Liquidity totaled approximately $230 million at ...

The planned merger with the SPAC Voyager Acquisition (VACH.O), opens new tab values Veraxa, cancer drug developer, at about $1.3 billion excluding trust funds, Xlife said in a statement.